- Genetic basis of HCM
- New Frontiers: Gene therapy in HCM
- Myosin Inhibitors: Are they the philosophers’ stone for HCM?
- Controversies in HOCM treatment
- Is there a new role for betablockers?
- Is there any role for myectomy?
- Is septal alcohol ablation safe and effective?
- Controversies in HCM risk stratification
- Must we include genetics in SCD HCM risk-score?
- Role of MRI LGE and apical aneurism in risk stratification
- Role of blood pressure response
- Risk stratification in pediatric population
- Sports in HCM patients
CARDIAC TTR AMYLOIDOSIS (ATTR-CM)
- New treatments in cardiac ATTR
- Are DPD scintigraphy or cardiac MRI 100% specific for the diagnosis?
- When to start treatment in TTR carriers?
- When to start treatment in women?
- Role of cardiac MRI in the diagnosis
- Is LysoGB3 the solution for the diagnosis and the follow up?